Comparative Pharmacology

Head-to-head clinical analysis: CEPHALEXIN versus SEFFIN.

Peer-Reviewed Evidence

Differential Analysis

CEPHALEXIN vs SEFFIN

Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.

CEPHALEXIN

Cephalosporin Antibiotic

Category A/B

SEFFIN

Cephalosporin Antibiotic

Category C

Head-to-Head

Clinical Matrix

Mechanism of Action

Cephalexin is a first-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby inhibiting transpeptidation and disrupting cell wall cross-linking, leading to cell lysis and death.

SEFFIN is a brand name for cefazolin, a first-generation cephalosporin antibiotic. It inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death. It is bactericidal against susceptible organisms.

Clinical Dosing

Oral: 250-1000 mg every 6 hours; maximum 4 g/day.

1-2 g IV/IM every 6-8 hours; maximum 8 g/day.

Direct Interaction

None Documented

Half-Life

0.5-1.2 hours in normal renal function; prolonged to 5-30 hours in severe renal impairment (CrCl <10 mL/min)

Other Significant Interactions

Clinical Note

moderate

Cephalexin + Teriflunomide

"The serum concentration of Teriflunomide can be increased when it is combined with Cephalexin."

Clinical Note

moderate

Cephalexin + Haloperidol

"The metabolism of Haloperidol can be decreased when combined with Cephalexin."

Clinical Note

moderate

Cephalexin + Probenecid

"The serum concentration of Probenecid can be increased when it is combined with Cephalexin."

Clinical Note

moderate

Cephalexin + Sulfisoxazole